QUIK

ANALYST NOTE: QUICKLOGIC CORPORATION (QUIK) DATE: 2026-06-20 EVENT DATE: 2026-06-20

1. Structural Readiness

Classification: CONFIRMED-ACTIVE

• Conservative Entry: $8.44
• Breakout Level: $8.44 (implied by conservative entry)
• Current Price: $21.90
• Extension: +159.5% vs. conservative entry.

2. Thesis Layer

Primary Secular Thesis: Defense Modernization (C4ISR / Sensors / EW) Exposure: Tier Second-Order | Confidence: Low

QuickLogic is positioned as a beneficiary of the Defense Modernization thesis, specifically within the C4ISR (Command, Control, Communications, Computers, Intelligence, Surveillance, and Reconnaissance) and Electronic Warfare (EW) sectors. The company's role is that of a specialized provider of radiation-hardened programmable logic.

• Directness: The company is a direct beneficiary through its RadPro brand of radiation-hardened FPGAs. Evidence [E7] and [E8] confirm that RadPro is a trademarked brand for these devices, which are critical for aerospace and defense systems operating in high-radiation environments.
• Secondary Tailwinds: The company also benefits from the broader adoption of embedded FPGA (eFPGA) IP in industrial, infrastructure, and computing platforms (Evidence [E13], [E14]). However, the primary conviction driver remains the defense sector, where the company has secured multiple contracts since 2022 (Evidence [E15]).
• Conviction Weighting: While the secular theme is strong, the "low" confidence rating in the setup metadata suggests that the direct revenue exposure to high-growth defense programs is currently in the early stages of realization (e.g., MOUs and low-six-figure contributions) rather than mature, large-scale deployment.

3. Business Analysis

Business Model: QuickLogic operates as a fabless semiconductor company. Its revenue model is dual-track:

• Licensing: Licensing eFPGA IP to semiconductor companies for integration into ASICs and SoCs (Evidence [E9], [E17]).
• Discrete Sales: Developing and selling programmable logic semiconductor devices, including discrete eFPGAs (Evidence [E9], [E17]).

Operational Status (as of 2026-06-20):

• Revenue Guidance: Management provided Q2 2026 revenue guidance of $6 million (±10%) based on backlog and customer forecasts (Evidence [E5]).
• Growth Trajectory: Management stated a goal of delivering 50% to 100% year-over-year revenue growth in 2026 (Evidence [E1]).
• Product Pipeline:
• RadPro: The company has signed an MOU with one Defense Intelligence Base (DIB) to accelerate the evaluation of a potential RadPro chiplet application (Evidence [E3]).
• ASIC Design: A test ship for a new ASIC design is targeted for tape-out in the second half of 2026 (Evidence [E4]).
• Market Size: The global FPGA market was valued at ~$11.7 billion in 2025 and is projected to reach ~$19.3 billion by 2030 (Evidence [E14]).
• Financial Health:
• Liquidity: The company secured a $10 million secured revolving credit facility with Sunflower Bank, N.A., maturing in April 2029 (Evidence [E11]).
• Cash Runway: Management believes existing cash, $3.1 million in net proceeds from an Amended ATM Offering, and the new credit facility are sufficient to fund operations and capex for the next twelve months (Evidence [E12]).
• Margins: Management is modeling a non-GAAP gross profit margin of approximately 57% for the full year (Evidence [E6]).
• R&D Intensity: R&D expenses were $5.3 million (38% of revenue) for the fiscal year ended Dec 28, 2025, up from $5.8 million (30% of revenue) in 2024 (Evidence [E18]).

4. Archetype and Conviction

Archetype: Quality Compounder (with Growth Characteristics) Fit Analysis: The company fits the "Quality Compounder" archetype due to its high gross margins (57% target) and the recurring nature of IP licensing alongside discrete device sales. However, the high R&D spend (38% of revenue) and the early-stage nature of the defense contracts (MOUs, low-six-figure contributions) also introduce "Growth Leader" characteristics, albeit with higher execution risk.

Conviction Stack:

• Thesis Strength: Moderate. The defense theme is structural, but the company's direct revenue contribution is currently small (low-six-figure) relative to the total guidance.
• Evidence Quality: High. The evidence base is robust, containing specific earnings transcripts and SEC filings from May 2026 that detail guidance, product timelines, and liquidity.
• Setup Readiness: The setup is active, but the +159.5% extension is significant. The current ATR of 8.9% (Extreme) suggests the stock is in a high-volatility regime, which historically correlates with higher severe-loser rates if the trend reverses.
• Rerating Potential: The potential for rerating exists if the RadPro chiplet application moves from MOU to contract and the ASIC tape-out is successful. The SAM expansion mentioned in Evidence [E8] supports this.

5. Invalidations, Strengtheners, and Gaps

Invalidation Triggers:

• Fundamental: Failure to meet the Q2 revenue guidance of $6 million (±10%) or a significant delay in the RadPro chiplet evaluation or ASIC tape-out.
• Liquidity: A breach of the covenant on the new $10M credit facility or a failure to secure additional funding before the 12-month runway expires.

Strengtheners:

• Contract Conversion: Announcement of a signed contract (not just an MOU) with a DIB for the RadPro chiplet.
• Tape-out Success: Confirmation that the ASIC design tape-out in H2 2026 was successful and on schedule.
• Margin Expansion: Confirmation that the 57% gross margin target is met or exceeded, indicating operational leverage.

Evidence Gaps:

• Customer Concentration: The evidence does not explicitly name the specific DIB or the other customers in the backlog, making it difficult to assess concentration risk.
• Cash Burn Rate: While total cash and credit are known, the specific monthly burn rate relative to the $6M quarterly run rate is not explicitly detailed in the provided snippets, though the 12-month runway is confirmed.
• Competitive Landscape: No specific data on competitor pricing or market share shifts in the provided evidence.

PRIVATE ANALYST CALL

Judgment: Speculative Confidence: medium Key evidence: Management guidance for 50-100% YoY revenue growth in 2026; secured $10M revolving credit facility extending liquidity to 2029; confirmed RadPro MOU with a DIB for chiplet evaluation. Key risks: Extreme current ATR (8.9%) indicating high volatility and potential for sharp drawdowns; revenue contribution from defense programs currently limited to low-six-figures; high R&D intensity (38% of revenue) relative to current revenue scale. Sizing hint: Reduce position size significantly due to the 159% extension and extreme volatility; treat as a satellite holding rather than a core conviction. Expected path: Management expects the RadPro chiplet evaluation to accelerate and the ASIC tape-out to occur in H2 2026; if successful, this should drive the projected revenue growth and margin stability. Expected horizon: 12 to 18 months for the product milestones (tape-out and contract conversion) to materially impact the financials.